Catalio Capital Management, LP
Position in GPCR — Structure Therapeutics Inc.
CIK 1958125
NEW YORK, NY
Position in GPCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$12,309,267
-$5,279,997 QoQ
Shares Held
255,379
+1.0% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
2.57%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Catalio Capital Management, LP holds $360,864,886 across 31 Biotechnology names. GPCR ranks #12 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
560,308 | $47,021,047 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
432,014 | $32,081,359 | |
| 3 | ASND |
Ascendis Pharma A/S
|
129,111 | $29,531,559 | |
| 4 | SNDX |
Syndax Pharmaceuticals Inc
|
1,043,670 | $24,380,131 | |
| 5 | TERN |
Terns Pharmaceuticals, Inc.
|
409,031 | $21,564,114 | |
| 6 | DFTX |
Definium Therapeutics, Inc.
|
1,037,984 | $19,617,897 | |
| 7 | SLNO |
Soleno Therapeutics Inc
|
577,808 | $19,345,011 | |
| 8 | RARE |
Ultragenyx Pharmaceutical Inc.
|
850,797 | $17,824,197 |
All Filings in GPCR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,309,267 | 255,379 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,589,264 | 252,901 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $18,250,680 | 651,810 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,907,725 | 670,575 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,201,195 | 704,864 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $15,441,992 | 569,395 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||